Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Importance of the Topic

Benzodiazepines are widely prescribed psychotropic drugs with significant forensic and clinical relevance. Rapid and reliable quantification in urine is critical for toxicological screening, clinical diagnostics, and therapeutic monitoring. The growing sample volumes in forensic laboratories demand high-throughput analytical platforms to reduce turnaround time and maintain data quality.

Objectives and Study Overview

This study aims to develop and validate an ultrafast mass spectrometry method using Agilent RapidFire high-throughput solid-phase extraction coupled to triple quadrupole mass spectrometry for simultaneous quantification of six benzodiazepines in urine. The focus was on achieving a robust workflow with minimal sample cycle time and high analytical accuracy and precision.

Methodology

Sample Preparation:

• Urine samples spiked with benzodiazepine standards (50–12 500 ng/mL) and nordiazepam-D5 internal standard.
• Enzymatic hydrolysis with β-glucuronidase at 55–60 °C for 2 hours.
• Dilution (1:50) and centrifugation prior to analysis.

Chromatographic Conditions:

• Reversed-phase C4 SPE cartridge (Agilent RapidFire A2) for analyte enrichment.
• Cycle time of 14 seconds per sample, enabling over 250 injections per hour.

Used Instrumentation

• Agilent RapidFire 365 high-throughput SPE system.
• Agilent 6490 Triple Quadrupole Mass Spectrometer with MassHunter Qualitative and Quantitative Analysis B.05.00.

Main Results and Discussion

The method demonstrated linearity across 50–12 500 ng/mL for all target analytes with correlation coefficients (R2) above 0.99. Intraday and interday accuracy values were within ±15% and precision (coefficient of variation) was below 10%. Limits of detection were under 25 ng/mL for each benzodiazepine. Signal suppression was negligible and carryover was effectively managed by blank injections following high-concentration samples.

Benefits and Practical Applications

• Throughput exceeding 250 samples per hour compared with conventional LC/MS/MS workflows (<25 samples per hour).
• Significant reduction in analysis time and solvent consumption.
• Simplified sample preparation combining enzymatic hydrolysis with direct SPE/MS analysis.

Future Trends and Possibilities

Expansion of the assay to additional drug classes and incorporation of automated sample handling could further enhance throughput. Coupling with high-resolution mass spectrometry may enable broader untargeted screening, supporting comprehensive toxicological panels in clinical and forensic settings.

Conclusion

The RapidFire SPE/MS/MS workflow delivers accurate and precise quantification of benzodiazepines in urine at over tenfold the speed of traditional LC/MS/MS methods. This high-throughput approach fulfills the escalating demands of modern forensic toxicology laboratories for rapid, reliable drug screening.

References

• Parikh NR, Romm M, Miller VP. Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System. Agilent Technologies Application Note 5991-0833EN (2014).